D
Vir Biotechnology, Inc. VIR
$5.59 -$0.37-6.21%
Recommendation
Sell
Prev Close
$5.96
Volume
739,415
Avg Vol (90D)
1,849,602
Market Cap
$817.37M
Dividend & Yield
--
52-Week Range
$5.85 - $14.45
P/E (TTM)
--
EPS (TTM)
-$3.83
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Vir Biotechnology (VIR, $5.96) RSI Indicator left the oversold zone on April 03, 2025
4/4/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $5.96) price may climb as it broke lower Bollinger Band on Apr 03, 2025
4/4/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $5.96) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 3, 2025
4/4/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $6.48) RSI Indicator left the oversold zone on April 02, 2025
4/3/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $6.48) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 2, 2025
4/3/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $6.18) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 1, 2025
4/2/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $6.18) price may climb as it broke lower Bollinger Band on Apr 01, 2025
4/2/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $6.48) RSI Indicator left the oversold zone on March 31, 2025
4/1/2025 - Tickeron - Stocks
Vir Biotechnology Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution
3/31/2025 - Simply Wall St
WINTON GROUP Ltd Sells 38,730 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
3/31/2025 - MarketBeat
Artisan Partners Limited Partnership Makes New Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)
3/30/2025 - MarketBeat
Vir Biotechnology (VIR, $6.7) RSI Indicator left the oversold zone on March 28, 2025
3/29/2025 - Tickeron - Technical Analysis
Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year Low - Time to Sell?
3/27/2025 - MarketBeat
Vir Biotechnology (VIR, $6.59) RSI Indicator left the oversold zone on March 26, 2025
3/27/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $6.95) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 25, 2025
3/26/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $7.2) RSI Indicator left the oversold zone on March 24, 2025
3/25/2025 - Tickeron - Stocks
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
3/21/2025 - PR Newswire
Commit To Purchase Vir Biotechnology At $5, Earn 12% Annualized Using Options
3/18/2025 - Stock Options Channel
How The Parts Add Up: VBK Headed For $340
3/17/2025 - ETF Channel
Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic ...
3/13/2025 - GuruFocus
Vir Biotechnology enrolls first patient in ECLIPSE program
3/13/2025 - The Fly
Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta
3/13/2025 - Business Wire
Vir Biotechnology (VIR, $7.37) RSI Indicator left the oversold zone on March 10, 2025
3/11/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $7.37) RSI Indicator left the oversold zone on March 10, 2025
3/11/2025 - Tickeron - Stocks
Vir Biotechnology (VIR, $8.2) RSI Indicator left the oversold zone on March 04, 2025
3/5/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$74.21M
EBITDA (TTM)
-$519.59M
EBIT (TTM)
-$534.14M
Net Income (TTM)
-$521.96M
Balance Sheet
Total Assets (Q)
$1.40B
Total Debt (Q)
$97.89M
Total Liabilities (Q)
$248.43M
Book Value Per Share (Q)
$8.40
Cash Flow
Cash from Operations (TTM)
-$446.35M
Cash from Investing (TTM)
$499.37M
Cash from Financing (TTM)
$4.39M
Net Change in Cash (TTM)
$57.40M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
1.36
7-Day Total Return
-15.17%
30-Day Total Return
-41.59%
60-Day Total Return
-29.15%
90-Day Total Return
-19.57%
Year to Date Total Return
-23.11%
1-Year Total Return
-40.97%
2-Year Total Return
-76.02%
3-Year Total Return
-77.93%
5-Year Total Return
-84.77%
52-week Low
Apr 03, 2025 - $5.85
52-week High
Jan 08, 2025 - $14.45
Valuation
Market Cap
$817.37M - Small Cap
Enterprise Value
$9.92M
Price/Sales (TTM)
10.99
Price/Book (Q)
0.71
Dividends and Shares
Shares Outstanding
136.81M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vir.bio
Phone Number
415 906 4324
Address
1800 Owens Street
San Francisco, CA 94158
Country
United States
Year Founded
2016
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and... more
NASDAQ 04/04/2025 12:38PM Eastern Quotes delayed
Weiss Ratings